top of page
Science, engineering & technology news
Find all of the latest science, technology and engineering news below including all updates from the North East Technology Park (NETPark), success stories for NETPark’s tenant companies and market breakthroughs in new research in areas such as printable electronics, photonics, microelectronics and nanotechnology.
IBI Feature: Accelerating Drug Discovery for Diseases of Ageing: In Vivo High Throughput Screening With C. elegans
IBI Feature: Accelerating Drug Discovery for Diseases of Ageing: In Vivo High Throughput Screening With C. elegans
Dec 10, 2025
Upcoming Podcast Spotlight: Magnitude Biosciences Takes Molecules to Market
Upcoming Podcast Spotlight: Magnitude Biosciences Takes Molecules to Market
Nov 26, 2025
Magnitude Biosciences Celebrates Seven Years at the Heart of NETPark
From an academic idea to a thriving high-growth biotech company, Magnitude Biosciences Ltd is celebrating seven years of scientific innovation and commercial success at NETPark.
Sep 26, 2025
Magnitude Biosciences CEO Dr Fozia Saleem Featured on Cover of N Magazine
Magnitude Biosciences Ltd, a pioneering biotech company based at The North East Technology Park (NETPark), is celebrating a major milestone as its Chief Executive, Dr Fozia Saleem, appears on the cover of N magazine.
Sep 24, 2025
Magnitude Biosciences Welcomes New Business Development Manager
Magnitude Biosciences has announced the appointment of Cheryl Dean as its new Business Development Manager.
Sep 22, 2025
Magnitude Biosciences: Durham University Spinout Gains Global Recognition for Worm-Based Drug Discovery
A successful business startup, founded by David Weinkove, a Professor in our Biosciences department, and a former colleague, Chris Saunter, recently featured in a series of articles about entrepreneurs in The Times newspaper.
Sep 8, 2025
Magnitude Biosciences Strengthens Team with Strategic Appointments
Magnitude Biosciences, a pioneering biotech company, has announced two key appointments as part of its continued growth and innovation strategy.
Aug 15, 2025
Magnitude Biosciences secures over £700,000 to accelerate in vivo high-throughput drug discovery platform
Magnitude Biosciences, a specialist contract research organisation (CRO) in County Durham offering in vivo discovery of treatments for age-related conditions and other diseases using C. elegans, has secured over £700,000 in combined funding to scale up its high-throughput screening (HTS) platform.
May 28, 2025
Magnitude Biosciences: Revolutionising Research:
Contract research organisation Magnitude Biosciences is projecting significant growth as it looks to tap into the multi-billion-pound...
Nov 14, 2023
bottom of page